FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

SFJ Pharma BLA for Blood Thinner Reversal Agent

SFJ Pharmaceuticals says it has closed the sale and transfer of assets related to bentracimab from PhaseBio Pharmaceuticals, and it is planning to fil...

latest-news-card-1
Human Drugs

Improve HHS Oversight of Pathogen Research: GAO

The Government Accountability Office says HHS could improve its oversight of research involving enhanced potential pandemic pathogens.

latest-news-card-1
Human Drugs

CDER Continuing QMM Program Development

The CDER Office of Pharmaceutical Quality says its two Quality Management Maturity pilots provided insights into how better to develop and implement a...

latest-news-card-1
Federal Register

Panel to Review Isotretinoin REMS Changes

Federal Register notice: FDA announces a 3/28-29 a joint advisory committee meeting to discuss proposed changes to the isotretinoin iPLEDGE Risk Evalu...

latest-news-card-1
Human Drugs

Stakeholder Suggestions for IHC Q5A Guidance

Two pharmaceutical associations suggest ways to clarify an International Council on Harmonization draft guidance on evaluating the viral safety of bio...

latest-news-card-1
Federal Register

FDA Permanently Debars Product Testing Lab Owner

Federal Register notice: FDA issues an order permanently debarring Gabriel J. Letizia, Jr from providing services related to an approved or pending dr...

latest-news-card-1
Federal Register

Ofirmev Not Withdrawn Due to Safety/Efficacy

Federal Register notice: FDA determines that Mallinckrodts Ofirmev (acetaminophen) injection, 1,000 mg/100 ml, was not withdrawn for safety or effecti...

latest-news-card-1
Human Drugs

FDA Denies Petition on Gabapentin Scheduling

FDA denies a citizen petition from advocacy group Public Citizen that urged it and the Drug Enforcement Administration to open proceedings to place ga...

latest-news-card-1
Human Drugs

Merck Fixing Nitrosamine Formation in Januvia Batches

Merck says it has identified the root cause of nitrosamine formation in certain Januvia (sitagliptin) batches.

latest-news-card-1
Human Drugs

Sterile Drug Issues at Optum Infusion

FDA warns Chandler, AZ-based Optum Infusion Services about adulterated sterile drug products.